0 (0%)		09-27 09:29
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	36.27	1-year :	42.37
Resists	First :	31.05	Second :	36.27
Pivot price	31.05
Supports	First :	30.96	Second :	30.89
MAs	MA(5) :	31.05	MA(20) :	31.05
	MA(100) :	30.98	MA(250) :	31.23
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	100	D(3) :	100
RSI	RSI(14): 47.2
52-week	High :	32.68	Low :	29.29

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PDEV ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 63 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

Sat, 20 Sep 2025
Temporary Immersion Bioreactor System (TIBS): A breakthrough for standardized, high-quality production of plant-derived extracellular vesicles from food-medicine homology plants - EurekAlert!

Wed, 03 Sep 2025
Griffey Geiss - Pitcher List

Fri, 02 May 2025
In vitro expression of the goose astrovirus Cap protein delivered with a duck enteritis virus vector - BMC Veterinary Research

Sun, 20 Apr 2025
Hulu error code P-DEV318: What is it and how to fix it? - Android Authority

Fri, 08 Nov 2024
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial - American Heart Association Journals

Fri, 08 Nov 2024
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial - American Heart Association Journals

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.